| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.3M | — | -15.8% |
| Cost of Revenue | $2.5M | — | -26.7% |
| Gross Profit | $3.8M | — | -6.6% |
| R&D Expense | $2.4M | — | +2.0% |
| SG&A Expense | $4.8M | — | +5.9% |
| Operating Income | -$6.0M | — | -0.9% |
| Net Income | -$5.9M | — | -0.7% |
| EPS (Basic) | -$0.06 | — | +14.3% |
| EPS (Diluted) | -$0.06 | — | +14.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.6M | +8.9% | +37.9% |
| Accounts Receivable | $5.3M | -9.3% | +22.6% |
| Inventory | $10.5M | +9.7% | +7.0% |
| Current Assets | $36.0M | +6.4% | +39.0% |
| Total Assets | $54.0M | +3.4% | +18.2% |
| Current Liabilities | $23.1M | +3.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | -93.5% |
| Investing Cash Flow | -$79K | — | — |
| Financing Cash Flow | $4.7M | — | — |
| -4.7% |
| Total Liabilities | $34.4M | +2.7% | -8.3% |
| Stockholders' Equity | $14.4M | +6.5% | +398.5% |